site stats

Glaxosmithkline sec filings

WebMar 29, 2024 · Naples Global Advisors LLC lifted its stake in shares of GSK plc (NYSE:GSK - Get Rating) by 8.1% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 44,304 shares of the pharmaceutical company's stock after acquiring an addition WebApr 11, 2024 · Adaptimmune and GSK are targeting transfer of sponsorship for GSK IGNYTE-ESO clinical trial (NCT03967223) and long-term follow-up clinical trial (NCT03391778) during Q3 of 2024. The parties are collaborating to ensure a smooth transition. ... Current Reports on Form 8-K, and other filings with the Securities and …

SEC.gov Filings & Forms - EDGAR

WebApr 15, 2024 · If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§240.13d-1(e ... family content filtering https://boldinsulation.com

EDGAR Entity Landing Page - sec.gov

WebApr 14, 2024 · Glaxosmithkline Capital Plc (1224544) SEC Filing 6-K Foreign Issuer Report for the period ending Thursday, April 14, 2024. Home. SEC Filings. ... Screenshots of actual 10-K and 10-Q SEC Filings in PDF, Word and Excel formats. Last10K.com Member Feature. Export Annual and Quarterly Reports to Adobe Acrobat (PDF), … WebApr 14, 2024 · Fri., April 14, 2024 MarketBeat International Assets Investment Management LLC bought a new stake in GSK plc ( NYSE:GSK - Get Rating) in the … WebApr 3, 2024 · Mon., April 3, 2024 MarketBeat Kooman & Associates purchased a new stake in GSK plc ( NYSE:GSK - Get Rating) in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm purchased 5,694 shares of the pharmaceutical company's stock, valued at approximately $200,000. family contact worker role

Surface Oncology Announces Exclusive License Agreement with GSK …

Category:Glaxosmithkline Plc (GSK) 10K Annual Reports & 10Q …

Tags:Glaxosmithkline sec filings

Glaxosmithkline sec filings

Johnson Midwest Financial LLC Increases Stake in GSK plc (NYSE:GSK …

WebApr 14, 2024 · Concord Wealth Partners bought a new stake in GSK plc (NYSE:GSK – Get Rating) during the fourth quarter, according to the company in its most recent 13F filing with the SEC.The institutional ... WebTypes of filings include: Registration Statement - details of the business and type of investments offered. 10-K Report - a comprehensive annual report submitted within 90 …

Glaxosmithkline sec filings

Did you know?

WebJun 23, 2024 · In 2024, GSK shareholders will receive dividends from GSK and New Consumer Healthcare due to the expected mid-year timing of the demerger. Together, these are expected to amount to approximately 55p per share for the year, assuming a New Consumer Healthcare dividend at the lower end of the previously announced 30-50% … WebThese reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and …

WebApr 13, 2024 · Fifth Third Bancorp decreased its position in GSK plc (NYSE:GSK – Get Rating) by 47.8% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). WebAug 27, 2024 · CARLSBAD, Calif., Aug. 27, 2024 /PRNewswire/ -- Ionis Pharmaceuticals, Inc. (Nasdaq: IONS), the leader in RNA-targeted therapeutics, announced today that GSK exercised its option to license Ionis' antisense medicines for people with chronic hepatitis B virus (CHB) infection following positive Phase 2 results.

WebMar 6, 2024 · Financial Statements, Disclosures and Schedules. Inside this 20-F Annual Report. Cover Page. Consolidated Cash Flow Statement. Consolidated Income … WebDownload our 2024 Annual Report and ESG Performance Report. Annual Report 2024 (PDF - 15.0MB) ESG Performance Report 2024 (PDF - 1.2MB) Cautionary statement (PDF - 66.1KB) Annual Report 2024 (iXBRL Viewer) Annual Report 2024 ESEF (ESEF reporting package) (ZIP - 13.5MB) 20-F 2024 (PDF - 4.1MB)

Web2024 Full year and fourth quarter results announcement Quarterly results Listen to the recording of the webcast 01 February 2024 GSK publishes Prospectus and Circular …

WebFind the latest SEC Filings data for GlaxoSmithKline PLC Common Stock (GSK) at Nasdaq.com. cookers gumtree scotlandWebMar 20, 2024 · GLAXOSMITHKLINE PLC (Filer) CIK: 0001131399 (see all company filings) IRS No.: 000000000 State of Incorp.: X0 Type: 20-F/A Act: 34 File No.: 001-15170 … cookers freestanding inductionWebJan 1, 2024 · Following any tender or exchange offer for stock of GlaxoSmithKline p.l.c., the decision to tender with respect to all such securities shall be exercised by Participants. The Company shall use its best efforts to provide each Participant with communications and instruction forms for the tender of shares allocated to the Participant’s Account. family contact supervisorWebMar 20, 2024 · SEC Home » Search the Next ... GLAXOSMITHKLINE PLC (Filer) CIK: 0001131399 (see all company filings) IRS No.: 000000000 State of Incorp.: X0 Type: 20-F/A Act: 34 File No.: 001-15170 Film No.: 18700645 SIC: 2834 Pharmaceutical Preparations Office of Life Sciences ... family content filterWebApr 13, 2024 · Fifth Third Bancorp decreased its position in GSK plc (NYSE:GSK - Get Rating) by 47.8% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 6,395 shares of the pharmaceutical company's stock after selling 5,846 shares during t cookers gas 55cmWebGSK CEO Emma Walmsley speaks to CNBC about our full year 2024 results Highlights Downloads FY 2024 results slides (PDF - 801.6KB) 2024 ESG updates at a glance (PDF - 831.9KB) FY 2024 results transcript … family contestWebGlaxoSmithKline PLC ADR SEC filings breakout by MarketWatch. View the GSK U.S. Securities and Exchange Commission reporting information. family content